IGF-1 LR3 50mg — Vial Spec, Reconstitution Math & COA

Overview & Capacity Specifications of the 50mg IGF-1 LR3 Format

A 50mg vial format of Long R3 Insulin-like Growth Factor-1 contains 50,000 micrograms of purified, lyophilized recombinant peptide. This mass is specifically targeted at high-volume experimental workflows, such as multi-plate receptor binding assays, continuous line cell culture studies, and comparative preclinical bioassays where maintaining a single manufacturing lot across hundreds of experimental wells is vital to eliminating batch-to-batch variability.

While specialized institutional labs require 50mg ultra-high-capacity vials for continuous automated pipelines, PX1 Research standardly packages individual analytical units in 1mg formats to ensure maximum stability and prevent multi-use degradation. Laboratory managers seeking standard analytical sizes can evaluate our flagship IGF-1 LR3 1mg supply, review the broader all peptides library for alternative recombinant factors, or contact our team through the wholesale accounts portal for custom institutional mass fills.

Molecular Structure, Receptor Affinity, and In Vitro Kinetics

IGF-1 LR3 is a synthetic, 83-amino-acid analog of human Insulin-like Growth Factor-1. It incorporates a glutamic acid-to-arginine substitution at position 3 (Arg3) alongside a 13-amino-acid N-terminal extension peptide. In native IGF-1, the N-terminal region mediates high-affinity binding to IGF-Binding Proteins (IGFBPs), which sequester the peptide in extracellular matrices and regulate its biological active life. Preclinical studies suggest that the Arg3 mutation and N-terminal extension produce electrostatic steric hindrance, dramatically decreasing affinity for inhibitory IGFBPs by up to 1,000-fold.

Because IGF-1 LR3 exhibits minimal sequestration by IGFBPs in culture media, the un-bound peptide remains fully available to interact with the Type 1 IGF Receptor (IGF-1R). In vitro data indicate that this prolonged bioavailability results in sustained autocrine and paracrine signaling activation, driving intracellular kinase cascades (specifically the PI3K-Akt and MAPK/ERK pathways) at significantly lower molar concentrations than wild-type IGF-1 over extended exposure windows.

Reconstitution Mathematics for 50mg Mass Vials

Calculating precise working concentrations from a high-mass 50mg lyophilized cake requires accurate volumetric measurement. Due to the high mass-to-volume ratio, directly adding small volumes of diluent creates dense stock solutions that require careful secondary dilution. Solubilization should begin with an acidic primary vehicle (such as 10mM to 100mM acetic acid) prior to final buffer dilution to ensure complete peptide dissolution without aggregation.

When adding diluent directly into a 50mg vial, researchers must account for target microgram yields per microliter unit:

• 1.0 mL Diluent Addition: Yields a stock concentration of 50.0 mg/mL (50,000 µg/mL, or 50 µg per 1 µL aliquot). This concentrated stock solution is optimal for long-term storage aliquots.

• 2.0 mL Diluent Addition: Yields a stock concentration of 25.0 mg/mL (25,000 µg/mL, or 25 µg per 1 µL aliquot). This volume provides a manageable viscosity for precise positive-displacement micropipetting.

• 3.0 mL Diluent Addition: Yields a stock concentration of 16.67 mg/mL (16,666.7 µg/mL, or 16.67 µg per 1 µL aliquot). This concentration suits direct primary working dilutions into assay culture media.

To easily model secondary serial dilutions for nanomolar cell culture protocols, lab technicians should utilize our automated reconstitution calculator to ensure mathematical precision before pipetting.

Aliquot Planning and Cryogenic Stability Protocols

Lyophilized IGF-1 LR3 exhibits robust long-term stability when stored at -20°C or -80°C in desiccated conditions. However, once reconstituted into aqueous solutions, recombinant proteins are prone to chemical degradation, including deamidation, oxidation of methionine residues, and physical aggregation. Repeated freeze-thaw cycles disrupt the tertiary structure of the peptide, drastically reducing in vitro bioactivity.

To preserve protein integrity from a reconstituted 50mg vial, laboratory staff must implement a rigorous master aliquot strategy. Immediately following complete primary dissolution, the stock solution should be divided into single-use micro-aliquots using low-binding microcentrifuge tubes. Aliquots should be flash-frozen in liquid nitrogen or dry ice/ethanol baths and stored at -80°C. Individual aliquots must only be thawed immediately prior to introduction into assay media, discarding any unused diluted portion.

Analytical Purity Standards: Lot-Matched COA, HPLC, and ESI-MS

High-throughput screening requires absolute chemical purity to ensure that cellular responses are attributable solely to the target molecule rather than structural variants or bacterial synthesis contaminants. PX1 Research enforces strict quality assurance across all peptide lots manufactured in our USA-based, GMP-compliant facilities.

Every batch undergoes independent verification at an ISO 17025 accredited laboratory. Analytical testing protocols include Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) to guarantee a chemical purity exceeding 98.0%, and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify the precise molecular mass of 9,111 Da. Furthermore, bacterial endotoxin testing is conducted via Chromogenic LAL assays to confirm levels remain strictly below <0.01 EU/µg. Researchers can verify batch-specific data by accessing our public COA repository.

Comparative Analysis: IGF-1 LR3 vs. Alternative Growth Factor Formats

Selecting the correct recombinant growth factor depends on the specific kinetics and experimental endpoints of the research model. In comparative cell culture models, distinct structural modifications yield divergent half-lives and signaling mechanics:

• IGF-1 LR3 vs. Native IGF-1: While native IGF-1 exhibits rapid clearance in serum-containing media due to IGFBP binding, IGF-1 LR3 bypasses binding proteins, maintaining steady receptor activation over extended culture durations.

• IGF-1 LR3 vs. IGF-1 DES: Truncated IGF-1 DES lacks the first three N-terminal amino acids, granting elevated potency in acidic local environments but exhibiting a much shorter biological half-life than the extended LR3 analog.

• IGF-1 LR3 vs. Pegylated MGF: Mechano Growth Factor variants such as Peg-MGF operate through alternative splice-variant pathways focused on early-phase tissue progenitor cell recruitment, whereas IGF-1 LR3 primary pathways drive sustained cellular hypertrophy and protein synthesis signaling.

Investigators exploring upstream secretagogues that stimulate endogenous hormone production may also review signaling models like CJC-1295 in our expanded research portal.

Determining Optimal Packaging Size: 1mg, 5mg, vs. High-Mass Fills

Selecting the correct vial size is critical for minimizing peptide waste and avoiding prolonged liquid storage. A single high-mass 50mg vial is designed exclusively for large-scale operations running automated fluid handlers or continuous pilot assays that consume tens of milligrams per week.

For small-scale exploratory studies, pilot cellular assays, or laboratories testing variable concentration parameters, smaller single-use standard formats are recommended. Utilizing multiple 1mg vials limits the exposure of master stocks to ambient temperatures, significantly reducing the risk of enzymatic degradation or accidental batch contamination compared to opening a single 50mg reservoir.

Solubility Limits, Solvents, and Buffer pH Sensitivity

Recombinant IGF-1 LR3 displays pH-dependent solubility characteristics. Attempting to reconstitute lyophilized high-mass peptide directly into neutral phosphate-buffered saline (PBS, pH 7.4) or basic culture media often results in incomplete dissolution, precipitation, or persistent cloudiness due to rapid protein aggregation near its isoelectric point.

The standard laboratory protocol requires initial solubilization in dilute acetic acid (10mM–100mM AcOH, pH ~3.0) to achieve a clear, fully dissolved concentration stock. Once fully solubilized in acidic solvent, the stock solution can be safely diluted into neutral cell culture buffers containing carrier proteins (such as 0.1% Bovine Serum Albumin) without risking immediate precipitation.

PX1 Research USA Quality & Laboratory Supply Guarantees

PX1 Research is dedicated to providing certified research-grade compounds strictly for laboratory research use only. All materials are synthesized in state-of-the-art USA facilities operating under full GMP compliance. We eliminate analytical ambiguity by publishing lot-traced HPLC and MS documentation for every batch.

To protect compound integrity, all orders are dispatched directly from our California and Arizona fulfillment centers with same-day shipping on orders placed Monday through Friday before cut-off times. Institutional accounts receive dedicated logistics support to maintain uninterrupted supply chains for ongoing research projects.